UiPath (NYSE:PATH) Stock Price Up 0.7%

UiPath Inc. (NYSE:PATH - Get Free Report)'s share price traded up 0.7% during mid-day trading on Thursday . The company traded as high as $19.29 and last traded at $19.25. 1,302,453 shares traded hands during mid-day trading, a decline of 85% from the average session volume of 8,911,960 shares. The stock had previously closed at $19.12.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Canaccord Genuity Group boosted their target price on shares of UiPath from $27.00 to $30.00 and gave the company a "buy" rating in a report on Friday, March 15th. JPMorgan Chase & Co. upgraded shares of UiPath from a "neutral" rating to an "overweight" rating and boosted their price objective for the stock from $22.00 to $28.00 in a research note on Thursday, March 14th. Truist Financial reiterated a "buy" rating and set a $32.00 price objective on shares of UiPath in a research note on Wednesday, March 20th. TD Cowen boosted their price objective on shares of UiPath from $25.00 to $28.00 and gave the stock an "outperform" rating in a research note on Thursday, March 14th. Finally, Royal Bank of Canada reiterated a "sector perform" rating and set a $29.00 price objective on shares of UiPath in a research note on Monday, April 1st. Nine investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $27.41.

UiPath Price Performance

The stock has a market capitalization of $10.83 billion, a price-to-earnings ratio of -111.96 and a beta of 0.96. The company has a 50-day simple moving average of $22.97 and a two-hundred day simple moving average of $21.44.

UiPath (NYSE:PATH - Get Free Report) last released its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share for the quarter, topping analysts' consensus estimates of ($0.04) by $0.10. The business had revenue of $405.25 million for the quarter, compared to analysts' expectations of $383.32 million. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. Research analysts anticipate that UiPath Inc. will post -0.04 EPS for the current year.

Insider Transactions at UiPath

In other UiPath news, CFO Ashim Gupta sold 16,000 shares of the business's stock in a transaction on Friday, March 15th. The stock was sold at an average price of $22.84, for a total transaction of $365,440.00. Following the completion of the transaction, the chief financial officer now owns 87,505 shares in the company, valued at approximately $1,998,614.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last three months, insiders sold 72,000 shares of company stock worth $1,591,360. Company insiders own 31.03% of the company's stock.

Institutional Trading of UiPath

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Mark Sheptoff Financial Planning LLC bought a new stake in shares of UiPath in the 4th quarter worth $25,000. HighMark Wealth Management LLC bought a new position in shares of UiPath during the 4th quarter valued at about $27,000. Tyler Stone Wealth Management acquired a new position in shares of UiPath in the 2nd quarter worth approximately $28,000. Cypress Capital Management LLC WY bought a new stake in shares of UiPath in the 4th quarter worth approximately $29,000. Finally, Fifth Third Bancorp raised its holdings in shares of UiPath by 2,005.3% in the 3rd quarter. Fifth Third Bancorp now owns 2,000 shares of the healthcare company's stock worth $34,000 after purchasing an additional 1,905 shares in the last quarter. 62.50% of the stock is currently owned by institutional investors.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.